Ana Paula Velez, MD
Attending Physician, Infectious Disease Section, Moffitt Cancer Center, Tampa, FL
Biographical Sketch | Areas of Expertise | Current Research | Publications
Fellowship, Division of Infectious Disease & International Medicine, University of South Florida, Tampa Florida.
Residency, Internal Medicine, Orlando Regional Medical Center, Orlando, FL
Internship, Internal Medicine, San Juan City Hospital, San Juan, Puerto Rico
Internship, General Medicine, Hospital General de Medellin, Medellin, Colombia
MD, Instituto Ciencias de la Salud, Medellin, Colombia
Phone: (813) 745-8565
Biographical Sketch
Areas of Expertise
Current Research
A Phase III Randomized, Double-Blinded, Placebo-Controlled Rrial to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an ART Including TMC114/RTV and an Investigator-Selected OBR in HIV-1 Infected Subjects with Limit to No Treatment Options. Tibotec (TMC125-C206) 2006-present
A randomized, controlled, partially blinded Phase IIb dose-finding trial of TMC125, in HIV-1 infected subjects with documented genotypic evidence of resistance to currently available NNRTIs and with at least three primary PI mutations. Tibotec – TMC125-C217, 2007-present
A Rendomized, Controlled, Parially Blinded Phase IIb Dose-Finding Trial of TMC125, in HIV-1 Infected Subjects with Documented Genotypic Evidence of Resistance to Currently Available NNRTIs and With at Least Three Primary PI Mutations.
A Phase II, Randomized, Blinded, 12-Week Comparison of Elvucitabine in Combination with Efavirenz and Tenofovir Versus Lamivudine in Combination with Efavirenz and Tenofovir in HIV-1 Infected, Treatment-Naïve Subjects with a 12-Week Extension Treatment Period. Achillion (ACH443-015) 2006-present
A Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy. SMART CPCRA. 2006-present.
A Randomized, Controlled, Open-Label Trial to Compare the Efficacy, Safety and Tolerability of TMC114/Ritonavir Versus Lopinavir/Ritonavir in Treatment-Naive HIV-1 Infected Subjects. This trial will be referred to as ARTEMIS. Tibotec (TMC114-C211) 2006-present
A Phase IIb, Randomized, Partially Blinded, Dose-Finding Trial of TM278 in Antiretroviral Naive HIV-1 Infected Subjects. Tibotec (TMC278-C204) 2006-present
A 96-Week, Phase IV, Randomized, Double-Blind, Multicenter Study of the Safety and Efficacy of Epzicom Versus Truvada Administered in Combination with Kaletra in Antiretroviral-naive HIV-1 Infected Subjects. HEAT. GlaxoSmithKline (EPZ104057) 2006-present
A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908/Ritonavir Given with Abacavir/Lamivudine Fixed Dose Combination. GlaxoSmithKline (COL100758) 2006-present
A Randomized, Controlled, Open-Tiral to Compare the Efficacy, Safety and Tolerability of TMC114/RTV versus LPV/RTV in Treatment-Experiences HIV-1 Infected Subjects. Tibotec (TMC114-C214) 2006-present
Publications
1. Velez AP, Baluch A, Greene J, Onichomycosis in neutropenic patients, Clinical of Infectious Diseases – pending submission 2008.
2. Velez AP, Greene J, Disseminated Fusarium Following Palm Tree Induced Injury in a Patient Following Allogeneic Stem Cell Transplantation Despite Voriconazole Prophylaxis,accepted: Infections in Medicine 2008.
3. Velez A, Menezes L, , Crespo A. Kawasaki-Like Syndrome During Immune Reconstitution in a Patient with AIDS. Ilustrated Cases HIV/AIDS Journal. September 2007.
4. Velez A, Menezes L, Crespo A. Kawasaki-Like Syndrome During Immune Reconstitution in a Patient with AIDS. AIDS Reader Journal. Volume 16 No. 9 September 2006.
Electronic Articles:
1. Gompf S, Velez AP, Leptospirosis, pending submission, e-medicine 2008.
2. Nadler J, Velez A. Promising New Antiretrovirals. HIV Carelink Journal. Volume 7 Issue 2; February 16, 2006.
Textbooks and Chapters:
Longo S, Velez A, Sanchez A. Manual Clinico De La Via Aerea (clinical manual of the air way) Chapter III, Clinical evaluation of the air way. Published in 1999.